- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.60 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x MN: MANGANESE (II) ION(Non-covalent)
- 6 x ZN: ZINC ION(Non-covalent)
ZN.2: 6 residues within 4Å:- Chain A: H.36, D.45, H.178, E.183
- Ligands: MN.1, CRN.31
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:H.36, A:D.45, A:E.183, A:E.183
ZN.4: 6 residues within 4Å:- Chain B: H.36, D.45, H.178, E.183
- Ligands: MN.3, CRN.32
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:H.36, B:D.45, B:E.183, B:E.183
ZN.6: 6 residues within 4Å:- Chain C: H.36, D.45, H.178, E.183
- Ligands: MN.5, CRN.33
4 PLIP interactions:4 interactions with chain C- Metal complexes: C:H.36, C:D.45, C:E.183, C:E.183
ZN.8: 6 residues within 4Å:- Chain D: H.36, D.45, H.178, E.183
- Ligands: MN.7, CRN.34
4 PLIP interactions:4 interactions with chain D- Metal complexes: D:H.36, D:D.45, D:E.183, D:E.183
ZN.10: 6 residues within 4Å:- Chain E: H.36, D.45, H.178, E.183
- Ligands: MN.9, CRN.35
4 PLIP interactions:4 interactions with chain E- Metal complexes: E:H.36, E:D.45, E:E.183, E:E.183
ZN.12: 6 residues within 4Å:- Chain F: H.36, D.45, H.178, E.183
- Ligands: MN.11, CRN.36
4 PLIP interactions:4 interactions with chain F- Metal complexes: F:H.36, F:D.45, F:E.183, F:E.183
- 18 x SO4: SULFATE ION(Non-functional Binders)
SO4.13: 4 residues within 4Å:- Chain A: A.51, K.54, R.55, Y.191
Ligand excluded by PLIPSO4.14: 3 residues within 4Å:- Chain A: R.59, Q.247, R.254
Ligand excluded by PLIPSO4.15: 5 residues within 4Å:- Chain A: R.113, K.147, E.256, F.257, P.258
Ligand excluded by PLIPSO4.16: 4 residues within 4Å:- Chain B: A.51, K.54, R.55, Y.191
Ligand excluded by PLIPSO4.17: 3 residues within 4Å:- Chain B: R.59, Q.247, R.254
Ligand excluded by PLIPSO4.18: 5 residues within 4Å:- Chain B: R.113, K.147, E.256, F.257, P.258
Ligand excluded by PLIPSO4.19: 4 residues within 4Å:- Chain C: A.51, K.54, R.55, Y.191
Ligand excluded by PLIPSO4.20: 3 residues within 4Å:- Chain C: R.59, Q.247, R.254
Ligand excluded by PLIPSO4.21: 5 residues within 4Å:- Chain C: R.113, K.147, E.256, F.257, P.258
Ligand excluded by PLIPSO4.22: 4 residues within 4Å:- Chain D: A.51, K.54, R.55, Y.191
Ligand excluded by PLIPSO4.23: 3 residues within 4Å:- Chain D: R.59, Q.247, R.254
Ligand excluded by PLIPSO4.24: 5 residues within 4Å:- Chain D: R.113, K.147, E.256, F.257, P.258
Ligand excluded by PLIPSO4.25: 4 residues within 4Å:- Chain E: A.51, K.54, R.55, Y.191
Ligand excluded by PLIPSO4.26: 3 residues within 4Å:- Chain E: R.59, Q.247, R.254
Ligand excluded by PLIPSO4.27: 5 residues within 4Å:- Chain E: R.113, K.147, E.256, F.257, P.258
Ligand excluded by PLIPSO4.28: 4 residues within 4Å:- Chain F: A.51, K.54, R.55, Y.191
Ligand excluded by PLIPSO4.29: 3 residues within 4Å:- Chain F: R.59, Q.247, R.254
Ligand excluded by PLIPSO4.30: 5 residues within 4Å:- Chain F: R.113, K.147, E.256, F.257, P.258
Ligand excluded by PLIP- 6 x CRN: N-[(E)-AMINO(IMINO)METHYL]-N-METHYLGLYCINE(Non-covalent)
CRN.31: 15 residues within 4Å:- Chain A: E.34, H.36, D.45, S.78, G.119, H.120, Y.121, W.154, W.174, D.175, E.177, H.178, E.183
- Ligands: MN.1, ZN.2
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:S.78, A:Y.121, A:W.174, A:H.178
- Salt bridges: A:H.36, A:H.120, A:H.178, A:E.183
CRN.32: 15 residues within 4Å:- Chain B: E.34, H.36, D.45, S.78, G.119, H.120, Y.121, W.154, W.174, D.175, E.177, H.178, E.183
- Ligands: MN.3, ZN.4
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:S.78, B:Y.121, B:W.174
- Salt bridges: B:H.36, B:H.120, B:H.178, B:E.183
- pi-Cation interactions: B:W.154
CRN.33: 15 residues within 4Å:- Chain C: E.34, H.36, D.45, S.78, G.119, H.120, Y.121, W.154, W.174, D.175, E.177, H.178, E.183
- Ligands: MN.5, ZN.6
7 PLIP interactions:7 interactions with chain C- Hydrogen bonds: C:Y.121, C:H.178
- Salt bridges: C:H.36, C:H.120, C:H.178, C:E.183
- pi-Cation interactions: C:W.154
CRN.34: 15 residues within 4Å:- Chain D: E.34, H.36, D.45, S.78, G.119, H.120, Y.121, W.154, W.174, D.175, E.177, H.178, E.183
- Ligands: MN.7, ZN.8
9 PLIP interactions:9 interactions with chain D- Hydrogen bonds: D:S.78, D:Y.121, D:W.174, D:E.183
- Salt bridges: D:H.36, D:H.120, D:H.178, D:E.183
- pi-Cation interactions: D:W.154
CRN.35: 15 residues within 4Å:- Chain E: E.34, H.36, D.45, S.78, G.119, H.120, Y.121, W.154, W.174, D.175, E.177, H.178, E.183
- Ligands: MN.9, ZN.10
10 PLIP interactions:10 interactions with chain E- Hydrogen bonds: E:S.78, E:Y.121, E:W.174, E:H.178, E:E.183
- Salt bridges: E:H.36, E:H.120, E:H.178, E:E.183
- pi-Cation interactions: E:W.154
CRN.36: 15 residues within 4Å:- Chain F: E.34, H.36, D.45, S.78, G.119, H.120, Y.121, W.154, W.174, D.175, E.177, H.178, E.183
- Ligands: MN.11, ZN.12
9 PLIP interactions:9 interactions with chain F- Hydrogen bonds: F:S.78, F:Y.121, F:W.174, F:E.183
- Salt bridges: F:H.36, F:H.120, F:H.178, F:E.183
- pi-Cation interactions: F:W.154
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yoshimoto, T. et al., Crystal structures of creatininase reveal the substrate binding site and provide an insight into the catalytic mechanism. J.Mol.Biol. (2004)
- Release Date
- 2004-01-27
- Peptides
- creatinine amidohydrolase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.60 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x MN: MANGANESE (II) ION(Non-covalent)
- 6 x ZN: ZINC ION(Non-covalent)
- 18 x SO4: SULFATE ION(Non-functional Binders)
- 6 x CRN: N-[(E)-AMINO(IMINO)METHYL]-N-METHYLGLYCINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yoshimoto, T. et al., Crystal structures of creatininase reveal the substrate binding site and provide an insight into the catalytic mechanism. J.Mol.Biol. (2004)
- Release Date
- 2004-01-27
- Peptides
- creatinine amidohydrolase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F